Kailera Therapeutics (KLRA) stock drops as the company posts late-stage trial data for oral GLP-1 candidate HRS-7535 in ...

IPO analysis: debt reduction, strong growth, but seasonal asset-heavy risks. Low EV/EBITDA may mask downside. Read more macro ...

Palo Alto Networks is rated a Hold after a magnificent 120% surge since April, as cybersecurity stocks went through the roof.

Achieve Life Sciences is a more derisked case now, thanks to successful financing, progress on shifting its supply chain and ...

Wayfair (W) outlook: weak consumer sentiment and home sales, U.S.

Iron Mountain earns a Buy rating on growth catalysts and a strong dividend story, with rising cash flow offsetting leverage ...

ScotiaBank upgrades Cloudflare (NET) to Sector Outperform with a $300 target, citing AI-driven traffic, Workers growth and ...

Amazon seeks to raise at least $25B from a U.S. dollar bond sale, according to a filing with the U.S. Securities and Exchange ...

CoreWeave’s revenue surged 112%, and the backlog hit $99.4B as financing improves. Click for more on CRWV stock prospects.

The semiconductor industry remains a critical pillar of technological innovation, powering everything from AI to ...

Bioventus stock is upgraded to a "Buy" amid a breakout driven by favorable regulatory developments. Here's what investors ...

FT Cboe Vest S&P 500 Dividend Aristocrats Target Income ETF is a Hold due to its likelihood of underperformance going forward ...